Over one million Americans travel to foreign countries for medical procedures each year, resulting in a multi-million dollar industry that, for the most part, is vastly unregulated.
Celine Halioua’s company, Loyal, is getting ready to enter clinical trials for its new canine drug. Her goal? To give you more healthy, happy years with your dogs.
In the aftermath of the Covid crisis, we need an independent, expert commission to get to the truth about the often deadly mistakes made by government and healthcare officials.
In the third part of this series, we illustrate the scope of hepatitis C infections in the United States and highlight the inequities in disease burden across various groups of people.
Infectious disease expert and biology professor Dave Wessner explores the scientific merit versus potential danger of experiments that change the genetic makeup of viruses and give them new abilities to better understand how they infect others and caus…